WesBanco Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

WesBanco Bank’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Hold	78,200	–	–	0.05%	269
2026 Q1	$1.74M	Hold	78,200	–	–	0.05%	262
2025 Q4	$2.09M	Hold	78,200	–	–	0.06%	223
2025 Q3	$1.67M	Hold	78,200	–	–	0.05%	276
2025 Q2	$1.69M	Buy	78,200 +26,400	+51%	+$491K	0.05%	262
2025 Q1	$860K	Hold	51,800	–	–	0.03%	338
2024 Q4	$951K	Hold	51,800	–	–	0.03%	322
2024 Q3	$797K	Hold	51,800	–	–	0.03%	357
2024 Q2	$842K	Buy	51,800 +25,000	+93%	+$403K	0.03%	329
2024 Q1	$496K	Buy	+26,800	New	+$664K	0.02%	415

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WesBanco Bank's ACAD Position: Q2 2026 in Review

WesBanco Bank held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 78,200 shares worth $1.98M. The position accounts for 0.05% of the portfolio, ranked #269.

WesBanco Bank first reported a position in ACAD in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.09M in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

WesBanco Bank held 78,200 shares of Acadia Pharmaceuticals worth $1.98M as of Q2 2026.
WesBanco Bank left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up 0.05% of WesBanco Bank's portfolio in Q2 2026, its #269 holding.
WesBanco Bank first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
WesBanco Bank's Acadia Pharmaceuticals position peaked at $2.09M in Q4 2025.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.